COX-2 Inhibitors and Cardiovascular Risk
Authors:
- Colin D FunkCFColin D Funk
- Garret A FitzGeraldGFGarret A FitzGerald
- 1 November 2007
- journal article
- review article
- Published by Wolters Kluwer Health in Journal of Cardiovascular Pharmacology
- Vol. 50 (5) , 470-479
Abstract
Placebo-controlled trials of nonsteroidal antiinflammatory drugs (NSAIDs) selective for COX-2 have revealed an enhanced risk for cardiovascular events. COX-2 inhibitors (coxibs) selectively reduce vascular prostacyclin synthesis without disrupting COX-1-derived thromboxane synthesis in platelets. Removal of prostacyclin's capacity to restrain all known endogenous compounds contributing to platelet activation and vasoconstriction is a well-recognized mechanism for coxib action in the cardiovascular system which can pre-dispose to thrombosis, hypertension and atherosclerosis. Novel mouse models of selective COX-2 inhibition and disruption of microsomal prostaglandin E synthase-1 have been exploited to reveal the relative importance of prostacyclin and prostaglandin E2 in cardiovascular homeostasis. This review discusses the background to our current understanding of coxibs and provides further information relating to recent mechanistic insights into how COX-2 inhibition promotes cardiovascular risk.Keywords
This publication has 137 references indexed in Scilit:
- COX-2 suppresses tissue factor expression via endocannabinoid-directed PPARδ activationJournal of Experimental Medicine, 2007
- Pharmacodynamic of cyclooxygenase inhibitors in humansProstaglandins & Other Lipid Mediators, 2007
- Deletion of microsomal prostaglandin E synthase-1 augments prostacyclin and retards atherogenesisProceedings of the National Academy of Sciences, 2006
- Low-grade chronic inflammation in regions of the normal mouse arterial intima predisposed to atherosclerosisJournal of Experimental Medicine, 2006
- Prostacyclin protects against elevated blood pressure and cardiac fibrosisCell Metabolism, 2005
- Molecular Cloning and Expression of Human Prostacyclin SynthaseBiochemical and Biophysical Research Communications, 1994
- Cloning of human gene encoding prostaglandin endoperoxide synthase and primary structure of the enzymeBiochemical and Biophysical Research Communications, 1989
- Identification of a cyclooxygenase-related gene and its potential role in prostaglandin formationBiochemical and Biophysical Research Communications, 1989
- Final Report on the Aspirin Component of the Ongoing Physicians' Health StudyNew England Journal of Medicine, 1989
- Endogenous biosynthesis of prostacyclin during cardiac catheterization and angiography in man.Circulation, 1985